2Bertholf MF, Mintz PD. Comparision of plateletpheresis using two cell separators and identical donors. Tranfusion,1989, 29(6) :521.
3Abreu ED, Strause RG, Corclie DG, et al. Providing leukocyte-reduced platelets using the CS-3000plus. J Clin Apheresis, 1996,11(1):27.
4Kretsehmer V. Side-effects and technical problem in cytapheresis with cell separators: results of a retrosrectivs multicenter study.Infusionsther Klin Ernahr, 1987,14(Suppl. 4) :7.
5Rintels PB, Kenney RM,Crowley JP, et al. Therapeutiu support of the patient with thrombocytopenia. Hematol Oncol Clin Nor Am,1994,8(6) : 1131.
6Mintz PD. Aprosepective comparison of platelet collection with the CS-3000 blood cell separator using the closed system and open system kits. Am J Clin Pathol ,1990,22(1):29.
7Koteba-Witkowska B, Mrowiec ZR,Daszynski J, et al. The influence of CS-3000plus plateletpheresis on blood donors and platelet concentrates. Mater Med Po1,1990,22(1) :29.
8Strauss RG,Ludwing GA, Rndels MJ, et al. Efficacy and safety of Fenwal CS-3000plus plateletpheresis performed at a rapid donor blood flow rate: rapidplateletphefis with Fenwal CS-3000plus. J Clin Apheresis,1991,6(1) :21.
